Correlation of serum vitamin D level with various aspects of polycystic ovarian syndrome
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20240139Keywords:
PCOS, Vitamin D, Triglyceride, Waist hip ratioAbstract
Background: Women with PCOS usually suffer from metabolic disturbances and IR, which might be associated with vitamin D metabolism. The objectives of this study are to determine the association of Vitamin-D with metabolic and endocrine parameters in PCOS women and to evaluate specific role of Vitamin-D in PCOS and to correlate the serum Vitamin-D level with various demographic, anthropometric, biochemical, metabolic and hormonal parameters in PCOS patient.
Methods: This case control study was carried out between July 2014 and June 2016 in the Department of Obstetrics and Gynaecology, IMS, BHU got ethical clearance from the institute. The study involved 192 patients with polycystic ovarian syndrome based on Rotterdam criteria and 200 healthy age matched women as controls. The data analysis was performed with the help of SPSS 16.0 version for windows.
Results: When study subjects are compared according to vitamin-D level (sufficiency, insufficiency and deficiency) there was significant difference for BMI (kg/m2), Waist Hip ratio and TRG (mg/dl). Vitamin-D had significant negative correlation with BMI (p=0.000); Waist:Hip ratio (p=0.012); Triglyceride (p=0.022).
Conclusions: Our study found an association between the high prevalence of obesity and metabolic dysfunction in women with PCOS, and vitamin-D deficiency could be secondary to obesity in such patients. Thus, vitamin-D deficiency cannot be considered as an independent factor through the development of metabolic disorders in PCOS patients.
References
Patra SK, Nasrat H, Goswami B, Jain A. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr. 2012;6:146-9.
Firouzabadi R, Aflatoonian A, Modarresi S, Sekhavat L, Mohammad TS. Therapeutic effects of calcium & vitamin D supplementation in women with PCOS. Complement Ther Clin Pract. 2012;18:85-8.
Li HW, Brereton RE, Anderson RA, Wallace AM, Ho CK. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism. 2011;60(10):1475-81.
Ardabili HR, Gargari BP, Farzadi L. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res. 2012;32:195-201.
Mousa A, Naderpoor N, Teede HJ, de Courten MP. Vitamin D and cardiometabolic risk factors and diseases. Minerva Endocrinol. 2015;40:213-30.
George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: Asystematic review and meta-analysis. Diabet Med. 2012;29:e142-50.
Wehr E, Trummer O, Giuliani A. Vitamin Dassociated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome. Eur J Endocrinol. 2011;164:741-9.
Ku YC, Liu ME, Ku CS, Liu TY. Relationship between vitamin D deficiency and cardiovascular disease. World J Cardiol. 2013;5:337-46.
Pilz S, Kienreich K, Rutters F, de Jongh R. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13:261-70.
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-8.
Holick M, Chen T, Sauter E. Vitamin D and skin physiology: a D-lightful sotry. J Bone Miner Res. 2007;22(2):32-9.
Harkness L, Cromer B. Low levels of 25-hydroxy vitamin D are associated with elevated parathyroid hormone in healthy adolescent females. Osteoporos Int. 2005;16:109-13.
Dawson-Hughes B, Heaney RP, Holick MF. Estimates of optimal vitamin D status. Osteoporos Int. 2005;16: 713-6.
Wehr E, Pilz S, Schweighofer N, Giuliani A, Kopera D, Pieber T, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009;161:575-82.
Muscogiuri G, Policola C, Prioletta A, Sorice G. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr. 2012; 31:476-80.
Asemi Z, Foroozanfard F, Hashemi T, Bahmani F. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Clin Nutr. 2014;34:586-92.
Carmina E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric. 2009;12:22-5.
Rahimi-Ardabili H, Pourghassem GB, Farzadi L. Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency. J Endocrinol Invest. 2013;36:28-32.
Yildizhan R, Kurdoglu M, Adali E. Serum 25- hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009;280:559-63.
Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril. 2009;92:1381-3.
Raja-Khan N, Shah J, Stetter CM. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: A randomized, controlled pilot trial. Fertil Steril. 2014;101:1740-6.
Gallea M, Granzotto M, Azzolini S. Insulin and body weight but not hyperandrogenism seem involved in seasonal serum 25-OH-vitamin D3 levels in subjects affected by PCOS. Gynecol Endocrinol. 2014;30:739-45.
Irani M, Minkoff H, Seifer DB, Merhi Z. Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS. J Clin Endocrinol Metab. 2014;99:E886-90.
Irani M, Seifer D, Minkoff H, Merhi Z. Vitamin D normalizes abnormally elevated serumantimullerian hormone levels usually noted in women with polycystic ovary syndrome. Obstet Gynecol. 2014; 123:189.
Michos ED, Melamed ML. Vitamin D and cardiovascular disease risk. Curr Opin Clin Nutr Metab Care. 2008;11:7-12.
Norman R, Dewailly D, Legro R, Hickey T. Polycystic ovary syndrome. Lancet. 2006;370:685-97.
